Cites several new studies in 2004 that point to Akt1 phosphorylation of the transcription factor Foxo as a central regulator of the body's balancing of muscle atrophy and hypertrophy. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on nature medicine.